|
SCLT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.20632409511745E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.29789529018854E-11 |
| Normal-vs-Stage2 |
1.409730E-04 |
| Normal-vs-Stage3 |
1.90649999998183E-06 |
| Normal-vs-Stage4 |
7.47460000005695E-07 |
| Stage1-vs-Stage2 |
8.487900E-02 |
| Stage1-vs-Stage3 |
3.445800E-01 |
| Stage1-vs-Stage4 |
4.197400E-01 |
| Stage2-vs-Stage3 |
4.482500E-02 |
| Stage2-vs-Stage4 |
2.269000E-01 |
| Stage3-vs-Stage4 |
1.812390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.15698594938385E-13 |
| Normal-vs-AfricanAmerican |
1.443670E-04 |
| Normal-vs-Asian |
5.308200E-02 |
| Caucasian-vs-AfricanAmerican |
5.764000E-01 |
| Caucasian-vs-Asian |
6.033200E-01 |
| AfricanAmerican-vs-Asian |
4.264400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.29813953925395E-12 |
| Normal-vs-Female |
1.35410005430714E-09 |
| Male-vs-Female |
2.761400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.500300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.79631914582524E-12 |
| Normal-vs-Age(61-80Yrs) |
2.47370013362058E-10 |
| Normal-vs-Age(81-100Yrs) |
4.401400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.909600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.991000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.429600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.037800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.656500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.399600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.437100E-04 |
| Normal-vs-Grade 2 |
5.71498404156046E-12 |
| Normal-vs-Grade 3 |
3.20380000307097E-08 |
| Normal-vs-Grade 4 |
4.13470000000249E-05 |
| Grade 1-vs-Grade 2 |
4.310200E-01 |
| Grade 1-vs-Grade 3 |
1.371850E-02 |
| Grade 1-vs-Grade 4 |
2.780600E-01 |
| Grade 2-vs-Grade 3 |
6.141400E-03 |
| Grade 2-vs-Grade 4 |
5.276200E-01 |
| Grade 3-vs-Grade 4 |
2.630000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.16926476781509E-12 |
| Normal-vs-ccB subtype |
1.83820000332346E-08 |
| ccA subtype-vs-ccB subtype |
2.260600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88810078682877E-11 |
| Normal-vs-N1 |
4.348300E-02 |
| N0-vs-N1 |
8.747200E-01 |
|
|
